PROTEIN EXPRESSION SYSTEMS MARKET ANALYSIS

Name: Protein Expression Systems Market Size and Trends
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Protein Expression Systems Market, Protein Expression Systems Market Report, Protein Expression Systems Industry Report, Protein Expression Systems Market Size, Protein Expression Systems Market Share, Protein Expression Systems Market Analysis, Protein Expression Systems Market Growth, Protein Expression Systems Market Trends, Protein Expression Systems Market Overview, Protein Expression Systems Market Forecast

Protein Expression Systems Market, By Expression System (Mammalian Expression Systems, Insect Expression Systems, Bacterial Expression Systems, Plant Expression Systems, Yeast Expression Systems, and Cell Free Expression Systems), By Product Type (Competent Cells, Instruments, Reagents, and Others), By Application (Protein Therapeutics, and Research Studies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published In : Dec 2018
Code : CMI2383
Pages :164
Formats :
Excel and PDF
Industry : Biotechnology

Protein Expression Systems MarketSize and Trends

The global protein expression systems market size was valued at US$ 1.2 billion in 2017, and is expected to witness a CAGR of 11.1% over the forecast period (2018 – 2026).

Global Protein Expression Systems Market Revenue (US$ Mn) Analysis, By Expression Systems, 2017

Source: Coherent Market Insights Analysis (2018)

Global Protein Expression Systems Market Value (US$ Mn) & Y-o-Y Growth (%)

Source: Coherent Market Insights Analysis (2018)

Market- Trends

Protein expression has become an important laboratory technology in biochemistry, molecular biology, and protein research as well as other scientific research fields, which require functional proteins for their research. The technology can also provide substrates or enzymes required for further analysis. Many chemically competent bacterial cells such as E. coli cells, suitable for protein expression and transformation, are available as research kits. Other commonly used protein expression systems include cell systems derived from insect, plants, yeast, and mammalian cells.

Furthermore, advances in protein-engineering technologies allow drug developers and manufacturers to modify and develop desirable functional characteristics of proteins of interest while maintaining product efficacy and safety. For instance, in 2017, HumanZyme Inc., a leading supplier of novel recombinant human proteins and growth factors expressed in human cells, announced the launch of HumanKine(r) Interferon gamma (IFN gamma) expressed from HEK293 cells. IFN gamma protects against bacterial, viral, and protozoan infections.